Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a medicine that is used to treat prostate cancer in adults. Pluvicto may be used to treat PSMA-positive prostate cancer that has spread to other ...
Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...
Tribune Content Agency on MSN
Mayo Clinic Q&A: Minimally invasive options use energy to treat enlarged prostate
I’m a 64-year-old man who was recently diagnosed with an enlarged prostate after experiencing issues with frequent urination, ...
The American Cancer Society estimates that 288,300 new cases of prostate cancer will be diagnosed in 2023. While the overall ...
The announcement that King Charles III was admitted to a private hospital Friday to undergo a procedure for an enlarged prostate has sparked interest in what is an extremely common condition among ...
BALTIMORE, Nov. 13, 2025 (GLOBAL NEWSWIRE) — The Urology Care Foundation (UCF), the official foundation of the American Urological Association (AUA), and the Prostate Cancer Foundation (PCF) today ...
Solution/product: The company is developing two diagnostics for prostate cancer, according to a company statement. Its lead test is designed to use prostate cancer biopsy tissue to help physicians ...
Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate cancer. They have shown that combining a small-molecule therapy called tumor ...
Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.
Conventional imaging methods have limited sensitivity for detecting metastatic prostate cancer. With appropriate, timely treatment vital to survival and quality of life, better imaging has been an ...
News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...
Final draft guidance on NHS use of the drug marks a "significant shift" from NICE's 2021 decision on the drug as a first-line treatment for newly diagnosed, advanced HSPC in combination with androgen ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback